Category: Regulatory/FDA

Pitts on the Politics of Drug Industry Sponsorship

Kamp on the Sunshine Act: Collaboration Key to Patient Care

Patients Need Education on Value of New Drugs

DDMAC Reorganized into Office of Prescription Drug Promotion

Determining Compliance with FDA Ad Rules Is Difficult

ProPublica Reporters Urged to Provide Context and Meaning to Payment Disclosures

DDMAC Calls Out Recent Marketing Violations in Enforcement Webinar

NIH Conflict-of-interest Final Rule Makes Changes to Current Practice

PLOS Drug Marketing Study: Behind the ugly headlines